0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
OTC Consumer Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-19S5901
Home | Market Reports | Health| Nursing
Global OTC Consumer Healthcare Market Size Status and Forecast 2021 2027
BUY CHAPTERS

OTC Consumer Healthcare - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-19S5901
Report
November 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Consumer Healthcare - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

OTC Consumer Healthcare - Market

OTC Consumer Healthcare - Market

The global market for OTC Consumer Healthcare was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Consumer Healthcare, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of OTC Consumer Healthcare by region & country, by Type, and by Application.
The OTC Consumer Healthcare market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Consumer Healthcare.
Market Segmentation

Scope of OTC Consumer Healthcare - Market Report

Report Metric Details
Report Name OTC Consumer Healthcare - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Johnson & Johnson, Pfizer, American Health, Abbott Laboratories, GlaxoSmithKline, Sanofi, Piramal Enterprises, Boehringer Ingelheim, Bayer, Teva Pharmaceutical Industries, Ipsen SA, Koninklijke DSM, Reckitt Benckiser, Lonza Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of OTC Consumer Healthcare manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of OTC Consumer Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of OTC Consumer Healthcare in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the OTC Consumer Healthcare - Market report?

Ans: The main players in the OTC Consumer Healthcare - Market are Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Johnson & Johnson, Pfizer, American Health, Abbott Laboratories, GlaxoSmithKline, Sanofi, Piramal Enterprises, Boehringer Ingelheim, Bayer, Teva Pharmaceutical Industries, Ipsen SA, Koninklijke DSM, Reckitt Benckiser, Lonza Group

What are the Application segmentation covered in the OTC Consumer Healthcare - Market report?

Ans: The Applications covered in the OTC Consumer Healthcare - Market report are Pharmacy or Drug Stores, Specialty Stores, Online Retailers

What are the Type segmentation covered in the OTC Consumer Healthcare - Market report?

Ans: The Types covered in the OTC Consumer Healthcare - Market report are OTC Pharmaceuticals, Dietary Supplement

Recommended Reports

Medical Devices

Healthcare IT & Solutions

Orthopedics & Consumables

1 Market Overview
1.1 OTC Consumer Healthcare Product Introduction
1.2 Global OTC Consumer Healthcare Market Size Forecast
1.3 OTC Consumer Healthcare Market Trends & Drivers
1.3.1 OTC Consumer Healthcare Industry Trends
1.3.2 OTC Consumer Healthcare Market Drivers & Opportunity
1.3.3 OTC Consumer Healthcare Market Challenges
1.3.4 OTC Consumer Healthcare Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OTC Consumer Healthcare Players Revenue Ranking (2023)
2.2 Global OTC Consumer Healthcare Revenue by Company (2019-2024)
2.3 Key Companies OTC Consumer Healthcare Manufacturing Base Distribution and Headquarters
2.4 Key Companies OTC Consumer Healthcare Product Offered
2.5 Key Companies Time to Begin Mass Production of OTC Consumer Healthcare
2.6 OTC Consumer Healthcare Market Competitive Analysis
2.6.1 OTC Consumer Healthcare Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by OTC Consumer Healthcare Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Consumer Healthcare as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 OTC Pharmaceuticals
3.1.2 Dietary Supplement
3.2 Global OTC Consumer Healthcare Sales Value by Type
3.2.1 Global OTC Consumer Healthcare Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global OTC Consumer Healthcare Sales Value, by Type (2019-2030)
3.2.3 Global OTC Consumer Healthcare Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmacy or Drug Stores
4.1.2 Specialty Stores
4.1.3 Online Retailers
4.2 Global OTC Consumer Healthcare Sales Value by Application
4.2.1 Global OTC Consumer Healthcare Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global OTC Consumer Healthcare Sales Value, by Application (2019-2030)
4.2.3 Global OTC Consumer Healthcare Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global OTC Consumer Healthcare Sales Value by Region
5.1.1 Global OTC Consumer Healthcare Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global OTC Consumer Healthcare Sales Value by Region (2019-2024)
5.1.3 Global OTC Consumer Healthcare Sales Value by Region (2025-2030)
5.1.4 Global OTC Consumer Healthcare Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America OTC Consumer Healthcare Sales Value, 2019-2030
5.2.2 North America OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe OTC Consumer Healthcare Sales Value, 2019-2030
5.3.2 Europe OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific OTC Consumer Healthcare Sales Value, 2019-2030
5.4.2 Asia Pacific OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America OTC Consumer Healthcare Sales Value, 2019-2030
5.5.2 South America OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa OTC Consumer Healthcare Sales Value, 2019-2030
5.6.2 Middle East & Africa OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OTC Consumer Healthcare Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions OTC Consumer Healthcare Sales Value
6.3 United States
6.3.1 United States OTC Consumer Healthcare Sales Value, 2019-2030
6.3.2 United States OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.3.3 United States OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe OTC Consumer Healthcare Sales Value, 2019-2030
6.4.2 Europe OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China OTC Consumer Healthcare Sales Value, 2019-2030
6.5.2 China OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.5.3 China OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan OTC Consumer Healthcare Sales Value, 2019-2030
6.6.2 Japan OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea OTC Consumer Healthcare Sales Value, 2019-2030
6.7.2 South Korea OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia OTC Consumer Healthcare Sales Value, 2019-2030
6.8.2 Southeast Asia OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India OTC Consumer Healthcare Sales Value, 2019-2030
6.9.2 India OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
6.9.3 India OTC Consumer Healthcare Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sun Pharmaceutical Industries
7.1.1 Sun Pharmaceutical Industries Profile
7.1.2 Sun Pharmaceutical Industries Main Business
7.1.3 Sun Pharmaceutical Industries OTC Consumer Healthcare Products, Services and Solutions
7.1.4 Sun Pharmaceutical Industries OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.1.5 Sun Pharmaceutical Industries Recent Developments
7.2 Glenmark Pharmaceuticals
7.2.1 Glenmark Pharmaceuticals Profile
7.2.2 Glenmark Pharmaceuticals Main Business
7.2.3 Glenmark Pharmaceuticals OTC Consumer Healthcare Products, Services and Solutions
7.2.4 Glenmark Pharmaceuticals OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.2.5 Glenmark Pharmaceuticals Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Profile
7.3.2 Johnson & Johnson Main Business
7.3.3 Johnson & Johnson OTC Consumer Healthcare Products, Services and Solutions
7.3.4 Johnson & Johnson OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.3.5 Pfizer Recent Developments
7.4 Pfizer
7.4.1 Pfizer Profile
7.4.2 Pfizer Main Business
7.4.3 Pfizer OTC Consumer Healthcare Products, Services and Solutions
7.4.4 Pfizer OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.4.5 Pfizer Recent Developments
7.5 American Health
7.5.1 American Health Profile
7.5.2 American Health Main Business
7.5.3 American Health OTC Consumer Healthcare Products, Services and Solutions
7.5.4 American Health OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.5.5 American Health Recent Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Profile
7.6.2 Abbott Laboratories Main Business
7.6.3 Abbott Laboratories OTC Consumer Healthcare Products, Services and Solutions
7.6.4 Abbott Laboratories OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Laboratories Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline OTC Consumer Healthcare Products, Services and Solutions
7.7.4 GlaxoSmithKline OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 Sanofi
7.8.1 Sanofi Profile
7.8.2 Sanofi Main Business
7.8.3 Sanofi OTC Consumer Healthcare Products, Services and Solutions
7.8.4 Sanofi OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.8.5 Sanofi Recent Developments
7.9 Piramal Enterprises
7.9.1 Piramal Enterprises Profile
7.9.2 Piramal Enterprises Main Business
7.9.3 Piramal Enterprises OTC Consumer Healthcare Products, Services and Solutions
7.9.4 Piramal Enterprises OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.9.5 Piramal Enterprises Recent Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Profile
7.10.2 Boehringer Ingelheim Main Business
7.10.3 Boehringer Ingelheim OTC Consumer Healthcare Products, Services and Solutions
7.10.4 Boehringer Ingelheim OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments
7.11 Bayer
7.11.1 Bayer Profile
7.11.2 Bayer Main Business
7.11.3 Bayer OTC Consumer Healthcare Products, Services and Solutions
7.11.4 Bayer OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.11.5 Bayer Recent Developments
7.12 Teva Pharmaceutical Industries
7.12.1 Teva Pharmaceutical Industries Profile
7.12.2 Teva Pharmaceutical Industries Main Business
7.12.3 Teva Pharmaceutical Industries OTC Consumer Healthcare Products, Services and Solutions
7.12.4 Teva Pharmaceutical Industries OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.12.5 Teva Pharmaceutical Industries Recent Developments
7.13 Ipsen SA
7.13.1 Ipsen SA Profile
7.13.2 Ipsen SA Main Business
7.13.3 Ipsen SA OTC Consumer Healthcare Products, Services and Solutions
7.13.4 Ipsen SA OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.13.5 Ipsen SA Recent Developments
7.14 Koninklijke DSM
7.14.1 Koninklijke DSM Profile
7.14.2 Koninklijke DSM Main Business
7.14.3 Koninklijke DSM OTC Consumer Healthcare Products, Services and Solutions
7.14.4 Koninklijke DSM OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.14.5 Koninklijke DSM Recent Developments
7.15 Reckitt Benckiser
7.15.1 Reckitt Benckiser Profile
7.15.2 Reckitt Benckiser Main Business
7.15.3 Reckitt Benckiser OTC Consumer Healthcare Products, Services and Solutions
7.15.4 Reckitt Benckiser OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.15.5 Reckitt Benckiser Recent Developments
7.16 Lonza Group
7.16.1 Lonza Group Profile
7.16.2 Lonza Group Main Business
7.16.3 Lonza Group OTC Consumer Healthcare Products, Services and Solutions
7.16.4 Lonza Group OTC Consumer Healthcare Revenue (US$ Million) & (2019-2024)
7.16.5 Lonza Group Recent Developments
8 Industry Chain Analysis
8.1 OTC Consumer Healthcare Industrial Chain
8.2 OTC Consumer Healthcare Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 OTC Consumer Healthcare Sales Model
8.5.2 Sales Channel
8.5.3 OTC Consumer Healthcare Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. OTC Consumer Healthcare Market Trends
    Table 2. OTC Consumer Healthcare Market Drivers & Opportunity
    Table 3. OTC Consumer Healthcare Market Challenges
    Table 4. OTC Consumer Healthcare Market Restraints
    Table 5. Global OTC Consumer Healthcare Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global OTC Consumer Healthcare Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies OTC Consumer Healthcare Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies OTC Consumer Healthcare Product Type
    Table 9. Key Companies Time to Begin Mass Production of OTC Consumer Healthcare
    Table 10. Global OTC Consumer Healthcare Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Consumer Healthcare as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global OTC Consumer Healthcare Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global OTC Consumer Healthcare Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global OTC Consumer Healthcare Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global OTC Consumer Healthcare Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global OTC Consumer Healthcare Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global OTC Consumer Healthcare Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global OTC Consumer Healthcare Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global OTC Consumer Healthcare Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global OTC Consumer Healthcare Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global OTC Consumer Healthcare Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global OTC Consumer Healthcare Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global OTC Consumer Healthcare Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global OTC Consumer Healthcare Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global OTC Consumer Healthcare Sales Value by Region (2019-2024) & (%)
    Table 27. Global OTC Consumer Healthcare Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions OTC Consumer Healthcare Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions OTC Consumer Healthcare Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions OTC Consumer Healthcare Sales Value, (2025-2030) & (US$ Million)
    Table 31. Sun Pharmaceutical Industries Basic Information List
    Table 32. Sun Pharmaceutical Industries Description and Business Overview
    Table 33. Sun Pharmaceutical Industries OTC Consumer Healthcare Products, Services and Solutions
    Table 34. Revenue (US$ Million) in OTC Consumer Healthcare Business of Sun Pharmaceutical Industries (2019-2024)
    Table 35. Sun Pharmaceutical Industries Recent Developments
    Table 36. Glenmark Pharmaceuticals Basic Information List
    Table 37. Glenmark Pharmaceuticals Description and Business Overview
    Table 38. Glenmark Pharmaceuticals OTC Consumer Healthcare Products, Services and Solutions
    Table 39. Revenue (US$ Million) in OTC Consumer Healthcare Business of Glenmark Pharmaceuticals (2019-2024)
    Table 40. Glenmark Pharmaceuticals Recent Developments
    Table 41. Johnson & Johnson Basic Information List
    Table 42. Johnson & Johnson Description and Business Overview
    Table 43. Johnson & Johnson OTC Consumer Healthcare Products, Services and Solutions
    Table 44. Revenue (US$ Million) in OTC Consumer Healthcare Business of Johnson & Johnson (2019-2024)
    Table 45. Johnson & Johnson Recent Developments
    Table 46. Pfizer Basic Information List
    Table 47. Pfizer Description and Business Overview
    Table 48. Pfizer OTC Consumer Healthcare Products, Services and Solutions
    Table 49. Revenue (US$ Million) in OTC Consumer Healthcare Business of Pfizer (2019-2024)
    Table 50. Pfizer Recent Developments
    Table 51. American Health Basic Information List
    Table 52. American Health Description and Business Overview
    Table 53. American Health OTC Consumer Healthcare Products, Services and Solutions
    Table 54. Revenue (US$ Million) in OTC Consumer Healthcare Business of American Health (2019-2024)
    Table 55. American Health Recent Developments
    Table 56. Abbott Laboratories Basic Information List
    Table 57. Abbott Laboratories Description and Business Overview
    Table 58. Abbott Laboratories OTC Consumer Healthcare Products, Services and Solutions
    Table 59. Revenue (US$ Million) in OTC Consumer Healthcare Business of Abbott Laboratories (2019-2024)
    Table 60. Abbott Laboratories Recent Developments
    Table 61. GlaxoSmithKline Basic Information List
    Table 62. GlaxoSmithKline Description and Business Overview
    Table 63. GlaxoSmithKline OTC Consumer Healthcare Products, Services and Solutions
    Table 64. Revenue (US$ Million) in OTC Consumer Healthcare Business of GlaxoSmithKline (2019-2024)
    Table 65. GlaxoSmithKline Recent Developments
    Table 66. Sanofi Basic Information List
    Table 67. Sanofi Description and Business Overview
    Table 68. Sanofi OTC Consumer Healthcare Products, Services and Solutions
    Table 69. Revenue (US$ Million) in OTC Consumer Healthcare Business of Sanofi (2019-2024)
    Table 70. Sanofi Recent Developments
    Table 71. Piramal Enterprises Basic Information List
    Table 72. Piramal Enterprises Description and Business Overview
    Table 73. Piramal Enterprises OTC Consumer Healthcare Products, Services and Solutions
    Table 74. Revenue (US$ Million) in OTC Consumer Healthcare Business of Piramal Enterprises (2019-2024)
    Table 75. Piramal Enterprises Recent Developments
    Table 76. Boehringer Ingelheim Basic Information List
    Table 77. Boehringer Ingelheim Description and Business Overview
    Table 78. Boehringer Ingelheim OTC Consumer Healthcare Products, Services and Solutions
    Table 79. Revenue (US$ Million) in OTC Consumer Healthcare Business of Boehringer Ingelheim (2019-2024)
    Table 80. Boehringer Ingelheim Recent Developments
    Table 81. Bayer Basic Information List
    Table 82. Bayer Description and Business Overview
    Table 83. Bayer OTC Consumer Healthcare Products, Services and Solutions
    Table 84. Revenue (US$ Million) in OTC Consumer Healthcare Business of Bayer (2019-2024)
    Table 85. Bayer Recent Developments
    Table 86. Teva Pharmaceutical Industries Basic Information List
    Table 87. Teva Pharmaceutical Industries Description and Business Overview
    Table 88. Teva Pharmaceutical Industries OTC Consumer Healthcare Products, Services and Solutions
    Table 89. Revenue (US$ Million) in OTC Consumer Healthcare Business of Teva Pharmaceutical Industries (2019-2024)
    Table 90. Teva Pharmaceutical Industries Recent Developments
    Table 91. Ipsen SA Basic Information List
    Table 92. Ipsen SA Description and Business Overview
    Table 93. Ipsen SA OTC Consumer Healthcare Products, Services and Solutions
    Table 94. Revenue (US$ Million) in OTC Consumer Healthcare Business of Ipsen SA (2019-2024)
    Table 95. Ipsen SA Recent Developments
    Table 96. Koninklijke DSM Basic Information List
    Table 97. Koninklijke DSM Description and Business Overview
    Table 98. Koninklijke DSM OTC Consumer Healthcare Products, Services and Solutions
    Table 99. Revenue (US$ Million) in OTC Consumer Healthcare Business of Koninklijke DSM (2019-2024)
    Table 100. Koninklijke DSM Recent Developments
    Table 101. Reckitt Benckiser Basic Information List
    Table 102. Reckitt Benckiser Description and Business Overview
    Table 103. Reckitt Benckiser OTC Consumer Healthcare Products, Services and Solutions
    Table 104. Revenue (US$ Million) in OTC Consumer Healthcare Business of Reckitt Benckiser (2019-2024)
    Table 105. Reckitt Benckiser Recent Developments
    Table 106. Lonza Group Basic Information List
    Table 107. Lonza Group Description and Business Overview
    Table 108. Lonza Group OTC Consumer Healthcare Products, Services and Solutions
    Table 109. Revenue (US$ Million) in OTC Consumer Healthcare Business of Lonza Group (2019-2024)
    Table 110. Lonza Group Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. OTC Consumer Healthcare Downstream Customers
    Table 114. OTC Consumer Healthcare Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. OTC Consumer Healthcare Product Picture
    Figure 2. Global OTC Consumer Healthcare Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 4. OTC Consumer Healthcare Report Years Considered
    Figure 5. Global OTC Consumer Healthcare Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Consumer Healthcare Revenue in 2023
    Figure 7. OTC Consumer Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. OTC Pharmaceuticals Picture
    Figure 9. Dietary Supplement Picture
    Figure 10. Global OTC Consumer Healthcare Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global OTC Consumer Healthcare Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Pharmacy or Drug Stores
    Figure 13. Product Picture of Specialty Stores
    Figure 14. Product Picture of Online Retailers
    Figure 15. Global OTC Consumer Healthcare Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global OTC Consumer Healthcare Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa OTC Consumer Healthcare Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa OTC Consumer Healthcare Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions OTC Consumer Healthcare Sales Value (%), (2019-2030)
    Figure 28. United States OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 34. China OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 36. China OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 46. India OTC Consumer Healthcare Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India OTC Consumer Healthcare Sales Value by Type (%), 2023 VS 2030
    Figure 48. India OTC Consumer Healthcare Sales Value by Application (%), 2023 VS 2030
    Figure 49. OTC Consumer Healthcare Industrial Chain
    Figure 50. OTC Consumer Healthcare Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart